Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease

This article was originally published here

The latest deal is said to leverage an existing agreement between the two companies established in 2018 for the development of mRNA vaccines for infectious diseases. Translate Bio

The post Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply